DiagnoCure Labs gets NY state permit

The New York State Department of Health has issued a clinical laboratory permit to DiagnoCure’s (TSX:CUR) Oncology Laboratories unit that allows the lab to test commercial samples originating in New York for the Previstage GCC colorectal staging test. “Previstage GCC is the only molecular test available to help better identify whether colorectal cancer has spread [...]

DiagnoCure restructures into 2 segments

DiagnoCure (TSX: CUR) has announced a reorganization into two business segments — an administrative headquarters in Quebec City to hold its patents and DiagnoCure Oncology Laboratories, its U.S. sales, marketing and service laboratory operations. As part of the realignment, CEO John Schafer will relocate to the U.S. to lead the commercialization of the Previstage GCC [...]